What: Seminar
Where: Klara Strand, Klarabergsviadukten 90, Stockholm
When: 19th October
We are organizing a seminar on “Drug development of Today and the Future” in collaboration with Abera Biosciences AB, Testa Center, RISE Research Institutes of Sweden, STUNS Life science and Business Sweden on the 19th of October 2022.
We are using this opportunity to invite you to participate to this event.
Be present to hear our own Eva-karin Gidlund and other eminent speakers engaged in the development of drugs talking about opportunities, problems and practical examples of the field where innovative ways of collaboration and new acquired skills were essential to surmount hurdles associated with our branch’s new demands.
The future is coming in fast, with it new challenges arise for all of us who are active in our industry. This seminar is intendent to be a platform for networking, exchange of ideas, best practices and possible solutions.
We eagerly await your participation in the seminar!
Preliminary program:
15:00 – Introduction
15:05 – Jesper Hedberg (Testa Center)
15:15 – Matti Sällberg (pre – GMP facillity)
15:25 – Eva-karin Gidlund (NorthX Biologics)
15:35 – Anna Ridderstad Wollberg (RISE)
15:45 – Coffee break
16:00 – Maria Alriksson (Abera Biosciences)
16:15 – Angelica Loskog (Lokon Pharma)
16:30 – Charlotte af Klercker & Britta Stenson (Business Sweden, followed by Q&A and discussions)
17:00 -19:00 – Mingle with snacks
NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.
For more news, follow us on LinkedIn
Amarna Therapeutics, a privately held biotechnology company specializing in transformative gene therapies, is pleased to announce its strategic collaboration with NorthX Biologics, a leading biologics manufacturing partner. This partnership represents ...
Neogap Therapeutics, a Swedish clinical-stage biotechnology company, has entered a strategic collaboration with NorthX Biologics, a leading CDMO, to advance manufacturing strategies for Neogap’s personalised cancer cell therapy. Supported by ...
Abera Bioscience AB (“Abera” or “the Company”) has been awarded a 1 million SEK grant from Vinnova to advance the development of its innovative pneumococcal vaccine, Ab-01.12, towards clinical trials. ...